- World rank, all time
- #39,137 of 42,892
- Rank in France
- #2,101 of 2,321
- Research works
- 131 ▲ 26% vs 2013–17
- Citations
- 1.1k 8.4 per fractional work
- Top-10% rate
- 7.4% record average 16.5%
- Open access
- 57% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.9×. Every wedge is a field page.
- Immunology and Microbiology 5.9×
- Economics, Econometrics and Finance 4.1×
- Health Professions 3.2×
- Medicine 3.0×
- Mathematics 2.3×
- Decision Sciences 1.8×
- Nursing 0.9×
- Biochemistry, Genetics and Molecular Biology 0.8×
- Agricultural and Biological Sciences 0.3×
- Engineering 0.3×
- Business, Management and Accounting 0.2×
- Environmental Science 0.2×
- Neuroscience 0.2×
- Physics and Astronomy 0.1×
- Materials Science 0.1×
- Psychology 0.1×
- Computer Science 0.1×
- Social Sciences 0.0×
Who are the top researchers at Takeda (France)?
Ranked on the composite score, Cinira Lefèvre lead among researchers whose main affiliation is Takeda (France).
- 1 Cinira Lefèvre France · #1,520,328 worldwide 5 citations · 19 works
Which keywords describe research at Takeda (France)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Cardiovascular Disease, Hypertension, Inflammation, Cardiovascular Events, Heart Failure, Clinical Guidelines and Global Burden.
- Rituximab
- Quality Characteristics
- Pathophysiology
- Cardiac Imaging
- Coronary Artery Disease
- Prevention
- Reactive Oxygen Species
- Pathogenesis
- Renal Denervation
- Antihypertensive Drugs
- Blood Pressure
- Magnetic Resonance Imaging
- Quality of Life
- Diabetes
- Diagnosis
- Oxidative Stress
- Clinical Guidelines
- Heart Failure
- Hypertension
- Inflammation
- Epidemiology
- Cardiovascular Disease
- Cardiovascular Events
- Risk Factors
- Obesity
- Global Burden
- Treatment
- Metabolic Syndrome
- Myocardial Infarction
- Diabetes Mellitus
- Cardiovascular Risk
- Meta-Analysis
- Metabolism
- Surgical Management
- Fermentation
- Atherosclerosis
- Cytokines
- Myocardial Perfusion
- Korean Traditional Food
- Proton Pump Inhibitors
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology13▲ 2.4×46 topics
- Inflammation9▲ 3.0×37 topics
- Cardiovascular Disease8▲ 5.4×21 topics
- Hypertension7▲ 14×12 topics
- Cardiovascular Events6▲ 26×4 topics
- Heart Failure5▲ 8.3×11 topics
- Risk Factors5▲ 3.4×8 topics
- Clinical Guidelines5▲ 11×7 topics
- Obesity4▲ 4.5×9 topics
- Oxidative Stress4▲ 1.84×20 topics
- Global Burden4▲ 5.8×6 topics
- Diagnosis4▲ 2.9×17 topics
- Treatment4▲ 2.3×16 topics
- Diabetes4▲ 5.6×11 topics
- Metabolic Syndrome4▲ 3.4×12 topics
- Quality of Life4▲ 2.1×14 topics
- Myocardial Infarction4▲ 10×5 topics
- Magnetic Resonance Imaging4▲ 7.1×4 topics
- Diabetes Mellitus3▲ 11×4 topics
- Blood Pressure3▲ 35×2 topics
- Cardiovascular Risk3▲ 6.9×7 topics
- Antihypertensive Drugs3▲ 43×1 topic
- Meta-Analysis3▲ 4.3×11 topics
- Renal Denervation3▲ 43×1 topic
- Metabolism3▲ 3.4×9 topics
- Pathogenesis3▲ 3.9×6 topics
- Surgical Management3▲ 4.8×7 topics
- Reactive Oxygen Species3▲ 4.1×9 topics
- Fermentation3▲ 13×3 topics
- Prevention2▲ 4.6×5 topics
- Atherosclerosis2▲ 4.7×7 topics
- Coronary Artery Disease2▲ 14×2 topics
- Cytokines2▲ 6.2×5 topics
- Cardiac Imaging2▲ 11×1 topic
- Myocardial Perfusion2▲ 20×1 topic
- Pathophysiology2▲ 6.0×5 topics
- Korean Traditional Food2▲ 48×1 topic
- Quality Characteristics2▲ 34×1 topic
- Proton Pump Inhibitors2▲ 18×2 topics
- Rituximab2▲ 8.7×4 topics
Which research topics does Takeda (France) publish most on?
By volume in 2022–2025: Healthcare Systems and Practices, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Mosquito-borne diseases and control and Health Systems, Economic Evaluations, Quality of Life.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Healthcare Systems and Practices General Health Professions 1 works
- 2 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 1 works
- 3 Mosquito-borne diseases and control Public Health, Environmental and Occupational Health 1 works
- 4 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 5 Cytomegalovirus and herpesvirus research Epidemiology 1 works
- 6 Viral Infections and Outbreaks Research Infectious Diseases 0 works
- 7 Complement system in diseases Immunology 0 works
- 8 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
- 9 Infectious Diseases and Tuberculosis Surgery 0 works
- 10 Spondyloarthritis Studies and Treatments Rheumatology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Takeda (France)'s research output changed?
Output in 2018–2022 was 26% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Puteaux
- Institut d'Economie Scientifique Et de Gestion
- Toshiba (France)
- Recordati (France)
- Bolloré (France)
- LEA Networks (France)
- Observatoire National sur les Effets du Réchauffement Climatique
- ELITech Group (France)
- Raytheon Technologies (France)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.